Dr. Pitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Center Dr
3rd Floor Cardiovascular Center
Ann Arbor, MI 48109Phone+1 888-287-1082- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1966 - 1966
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1960 - 1963
- Mount Sinai Beth Israel HospitalInternship, Transitional Year, 1959 - 1960
- University of Basel Faculty of MedicineClass of 1959
Certifications & Licensure
- MI State Medical License 1978 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I) Start of enrollment: 2008 Mar 01
- The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial.Rahul Aggarwal, Michael Szarek, Lawrence A Leiter, Renato D Lopes, Michael J Davies, Phillip Banks, Ph Gabriel Steg, Deepak L Bhatt, Christopher P Cannon, Bertram Pitt> ;European Journal of Heart Failure. 2024 Apr 17
- Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure - insights from TRANSFORM-HF.Pieter Martens, Shuang Li, Daniel Wojdyla, Chris J Kapelios, Wilfried Mullens, Fassil Ketema, Dong-Yun Kim, Eric L Eisenstein, Kevin Anstrom, W H Wilson Tang, Stephen ...> ;European Journal of Heart Failure. 2024 Apr 1
- Validation of the Klinrisk chronic kidney disease progression model in the FIDELITY population.Navdeep Tangri, Thomas Ferguson, Silvia J Leon, Stefan D Anker, Gerasimos Filippatos, Peter Rossing, Luis M Ruilope, Alfredo E Farjat, Youssef M K Farag, Patrick Schlo...> ;Clinical Kidney Journal. 2024 Apr 1
- Join now to see all
Journal Articles
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesBertram Pitt, MD, The New England Journal of Medicine
- Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure with Preserved, Mid-Range, and Reduced Ejection FractionBertram Pitt, JACC: Cardiovascular Imaging
- Join now to see all
Authored Content
- Oxford University Press Has Registered This DOI Pre-PublicationOctober 2018
- Declining Risk of Sudden Death in Heart FailureJuly 2017
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure — NEJMSeptember 1999
Press Mentions
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call TranscriptMarch 6th, 2023
- New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin’s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart FailureNovember 6th, 2022
- Finerenone: ‘Striking’ Cut in Pneumonia, COVID-19 RisksOctober 27th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: